Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

3(42.9%)

7Total

N/A(4)

Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03728478Phase 3Recruiting

STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS

Role: collaborator

NCT05859867Not ApplicableRecruiting

Bimbingamba Zerosix Third Phase: Studying Communities

Role: collaborator

NCT06410560Not ApplicableCompleted

Culture is Care: Training Workshop for Care Workers (VerbaCurant)

Role: collaborator

NCT06301009Not ApplicableNot Yet Recruiting

The AI-CAC Model for Subclinical Atherosclerosis Detection on Chest X-ray

Role: collaborator

NCT03348722Completed

Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START

Role: collaborator

NCT00998400Not ApplicableCompleted

Treatment of Depression in Acute Coronary Syndrome (ACS) Patients

Role: collaborator

NCT00551980Phase 3Completed

The Efficacy of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in a Working Community

Role: collaborator

NCT00457496Phase 3Completed

Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in Working Communities

Role: collaborator

All 8 trials loaded